EUVIMEDEUVIMED entdecken
Crossref

The Role of p-VEGFR2/p-AKT and HDAC1 in Apatinib-associated Inhibition of Gallbladder Cancer Cell Growth

Wei Huang, Yanmin Pang, Wenmei Zhao, Liang’e Xia, Luting Wang, Yingde Nong, Kai Xiao, Yichong Ning

Exploratory Research and Hypothesis in Medicine · 30.07.2026 · 11 (3)

DOI: 10.14218/erhm.2025.00077 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Exploratory Research and Hypothesis in Medicine, online erschienen am 29.06.2026. Verfasst von Wei Huang und 7 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Apatinib has been shown to be efficacious in the treatment of gallbladder cancer. However, the underlying mechanisms remain unclear. This study aimed to explore pathways related to the antitumor effects of apatinib at the cellular level in gallbladder cancer.

Zitieren

APA

Huang, W., Pang, Y., Zhao, W., Xia, L., Wang, L., Nong, Y., Xiao, K., & Ning, Y. (2026). The Role of p-VEGFR2/p-AKT and HDAC1 in Apatinib-associated Inhibition of Gallbladder Cancer Cell Growth. Exploratory Research and Hypothesis in Medicine, 11(3). https://doi.org/10.14218/erhm.2025.00077

Vancouver

Huang W, Pang Y, Zhao W, Xia L, Wang L, Nong Y, et al. The Role of p-VEGFR2/p-AKT and HDAC1 in Apatinib-associated Inhibition of Gallbladder Cancer Cell Growth. Exploratory Research and Hypothesis in Medicine. 2026;11(3). doi:10.14218/erhm.2025.00077

BibTeX
@article{Huang2026,
  author = {Huang, Wei and Pang, Yanmin and Zhao, Wenmei and Xia, Liang’e and Wang, Luting and Nong, Yingde and Xiao, Kai and Ning, Yichong},
  title = {The Role of p-VEGFR2/p-AKT and HDAC1 in Apatinib-associated Inhibition of Gallbladder Cancer Cell Growth},
  journal = {Exploratory Research and Hypothesis in Medicine},
  year = {2026},
  volume = {11},
  number = {3},
  doi = {10.14218/erhm.2025.00077}
}
Kostenlos starten →